Giwa, Sebastian
Lewis, Jedediah K
Alvarez, Luis
Langer, Robert
Roth, Alvin E
Church, George M
Markmann, James F
Sachs, David H
Chandraker, Anil
Wertheim, Jason A http://orcid.org/0000-0001-5680-1067
Rothblatt, Martine
Boyden, Edward S
Eidbo, Elling
Lee, W P Andrew
Pomahac, Bohdan
Brandacher, Gerald
Weinstock, David M
Elliott, Gloria
Nelson, David
Acker, Jason P
Uygun, Korkut
Schmalz, Boris
Weegman, Brad P
Tocchio, Alessandro
Fahy, Greg M
Storey, Kenneth B
Rubinsky, Boris
Bischof, John
Elliott, Janet A W
Woodruff, Teresa K http://orcid.org/0000-0002-1197-3399
Morris, G John
Demirci, Utkan
Brockbank, Kelvin G M
Woods, Erik J
Ben, Robert N
Baust, John G
Gao, Dayong
Fuller, Barry
Rabin, Yoed
Kravitz, David C
Taylor, Michael J http://orcid.org/0000-0002-8406-134X
Toner, Mehmet
Article History
Received: 31 October 2016
Accepted: 28 April 2017
First Online: 7 June 2017
Competing interests
: J.K.L. is an officer of the Organ Preservation Alliance, a 501c3 non-profit organization, dedicated to advancing organ and tissue preservation. S.G. is an officer of Sylvatica Biotech, a cryopreservation biotech company, and Ossium Health, a bone marrow banking company. E.E. is CEO of the Association of Organ Procurement Organizations, a non-profit organization that represents the 58 US organ procurement organizations. E.B. is co-founder and consultant at Cognito Therapeutics and Expansion Technologies, senior advisor to Kernel, advisor to Inner Cosmos, Puretech, Constellation Diagnostics, and OccamzRazor, and consultant to Intellectual Ventures. J.F.M. is a consultant for Vicapsys. M.J.T. is supported in part by salary from Sylvatica Biotech, in which he also holds equity. G.C. has a financial interest in eGenesis. K.G.M.B. is an owner of Tissue Testing Technologies and has stock in Organ Recovery Systems. J.A.W.E. holds cryopreservation patents. E.J.W. is an officer of Ossium Health, a bone marrow banking company. D.K. is CEO of Organ Recovery Systems, a developer of organ preservation technologies. U.D. is a founder of, and has an equity interest in DxNow, Inc., a company that is developing microfluidic and imaging technologies for point-of-care diagnostic solutions, and Koek Biotech, a company that is developing microfluidic IVF technologies for clinical solutions. U.D.'s interests were reviewed and are managed with the aforementioned companies' and Stanford School of Medicine's conflict of interest policies. G.J.M. is a director of Asymptote Ltd., a GE Healthcare company that produces cryochain technologies for the clinical delivery of cell therapies. G.B. is a founding scientific advisor to Ossium Health. K.U. is an inventor on pending patents relevant to this study (WO/2011/002926; WO/2011/35223) and has a provisional patent application relevant to this study (MGH 22743). K.U. has a financial interest in Organ Solutions, a company focused on developing organ preservation technology. K.U.'s interests are managed by the Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies. M.R. is the founder and CEO of United Therapeutics. United Therapeutics Corporation is a biotech company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. Lung Biotechnology is a Public Benefit Company addressing the acute national shortage of transplantable lungs and other organs with a variety of technologies that either delay the need for such organs or expand the supply. D.H.S. is consultant for Econugenics, Immunotherapeutics and Ossium Health and is a board member of ITB-MED. G.M.F. declares that he is an officer of 21st Century Medicine, which is an organ cryopreservation company. A.R. is a cofounder and officer of Rejuvenate Healthcare, which provides consulting for management of end-stage-renal-disease patients.